Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies (Q34548815)

3 August 2017

Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies (English)

1 reference

3 August 2017

1 reference

34

1 reference

3 August 2017

Hanna Axelsson

15

0 references

Nikolas Herold

Nikolas Herold

1

0 references

Sean G Rudd

Sean G Rudd

2

0 references

Bianca Tesi

Bianca Tesi

16

0 references

Katja Pokrovskaja Tamm

Katja Pokrovskaja Tamm

José Manuel Calderón-Montaño

25

0 references

José M Calderón-Montaño

11

0 references

Thomas Lundbäck

Thomas Lundbäck

30

0 references

Per Kogner

Per Kogner

31

0 references

Thomas Helleday

Thomas Helleday

33

0 references

Jan-Inge Henter

Jan-Inge Henter

32

0 references

Ann-Sofie Jemth

Ann-Sofie Jemth

13

0 references

Andreas Höglund

18

Andreas Höglund

1 reference

3 August 2017

Ulrika Warpman Berglund

26

Ulrika Warpman-Berglund

1 reference

3 August 2017

20

Elisée Wiita

1 reference

3 August 2017

6

Cynthia B J Paulin

1 reference

3 August 2017

8

Anna Hagenkort

1 reference

3 August 2017

17

Nicholas C K Valerie

1 reference

3 August 2017

9

Juliane Kutzner

1 reference

3 August 2017

Linda Ljungblad

3

1 reference

3 August 2017

Kumar Sanjiv

4

1 reference

3 August 2017

Ida Hed Myrberg

5

1 reference

3 August 2017

Yaser Heshmati

7

1 reference

3 August 2017

Brent D G Page

10

1 reference

3 August 2017

Olga Loseva

12

1 reference

3 August 2017

Lorenzo Bulli

14

1 reference

3 August 2017

Julia Bladh

19

1 reference

3 August 2017

Mikael Sundin

21

1 reference

3 August 2017

Michael Uhlin

22

1 reference

3 August 2017

Georgios Rassidakis

23

1 reference

3 August 2017

Mats Heyman

24

1 reference

3 August 2017

Julian Walfridsson

27

1 reference

3 August 2017

Sören Lehmann

28

1 reference

3 August 2017

Dan Grandér

29

1 reference

3 August 2017

language of work or name

English

0 references

publication date

9 January 2017

1 reference

3 August 2017

1 reference

3 August 2017

23

1 reference

3 August 2017

2

1 reference

3 August 2017

256-263

1 reference

https://scigraph.springernature.com/pub.10.1038/nm.4265

3 August 2017

0 references

cites work

Important milestones in acute leukemia in 2013.

1 reference

Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells

21 January 2018

1 reference

A functional single-nucleotide polymorphism in the human cytidine deaminase gene contributing to ara-C sensitivity.

21 January 2018

1 reference

Potential mechanisms of resistance to cytarabine in AML patients

21 January 2018

1 reference

Pediatric AML: From Biology to Clinical Management

21 January 2018

1 reference

How I treat the older patient with acute myeloid leukemia

21 January 2018

1 reference

Drug resistance in childhood acute myeloid leukemia

21 January 2018

1 reference

Substrate cycles and drug resistance to 1-beta-D-arabinofuranosylcytosine (araC).

21 January 2018

1 reference

Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia

21 January 2018

1 reference

Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response

21 January 2018

1 reference

Identification of human homologue of mouse IFN-gamma induced protein from human dendritic cells

21 January 2018

1 reference

SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx

21 January 2018

1 reference

Structural basis of cellular dNTP regulation by SAMHD1.

21 January 2018

1 reference

A continuous enzyme-coupled assay for triphosphohydrolase activity of HIV-1 restriction factor SAMHD1

21 January 2018

1 reference

Correlating chemical sensitivity and basal gene expression reveals mechanism of action.

21 January 2018

1 reference

Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset.

21 January 2018

1 reference

Nuclear import of SAMHD1 is mediated by a classical karyopherin α/β1 dependent pathway and confers sensitivity to VpxMAC induced ubiquitination and proteasomal degradation

21 January 2018

1 reference

Effects of T592 phosphomimetic mutations on tetramer stability and dNTPase activity of SAMHD1 can not explain the retroviral restriction defect.

21 January 2018

1 reference

Clofarabine 5'-di and -triphosphates inhibit human ribonucleotide reductase by altering the quaternary structure of its large subunit

21 January 2018

1 reference

Vpx mediated degradation of SAMHD1 has only a very limited effect on lentiviral transduction rate in ex vivo cultured HSPCs

21 January 2018

1 reference

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia

21 January 2018

1 reference

Genomic Profiling of Pediatric Acute Myeloid Leukemia Reveals a Changing Mutational Landscape from Disease Diagnosis to Relapse

21 January 2018

1 reference

Downregulation of SAMHD1 expression correlates with promoter DNA methylation in Sézary syndrome patients.

21 January 2018

1 reference

SAMHD1 is down regulated in lung cancer by methylation and inhibits tumor cell proliferation

21 January 2018

1 reference

MicroRNA-181 expression regulates specific post-transcriptional level of SAMHD1 expression in vitro

21 January 2018

1 reference

The pathological role and prognostic impact of miR-181 in acute myeloid leukemia

21 January 2018

1 reference

miR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis

21 January 2018

1 reference

Anthracycline dose intensification in acute myeloid leukemia

21 January 2018

1 reference

Genetic factors influencing cytarabine therapy

21 January 2018

1 reference

SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage.

21 January 2018

1 reference

Aggressive CD8(+) epidermotropic cutaneous T-cell lymphoma associated with homozygous mutation in SAMHD1.

21 January 2018

1 reference

Heterozygous colon cancer-associated mutations of SAMHD1 have functional significance

21 January 2018

1 reference

A High-Throughput Enzyme-Coupled Assay for SAMHD1 dNTPase

21 January 2018

1 reference

MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool

21 January 2018

1 reference

A niche-like culture system allowing the maintenance of primary human acute myeloid leukemia-initiating cells: a new tool to decipher their chemoresistance and self-renewal mechanisms

21 January 2018

1 reference

Evidence for IFNα-induced, SAMHD1-independent inhibitors of early HIV-1 infection

21 January 2018

1 reference

Quantification of reverse transcriptase activity by real-time PCR as a fast and accurate method for titration of HIV, lenti- and retroviral vectors

21 January 2018

1 reference

Genome-scale CRISPR-Cas9 knockout screening in human cells

21 January 2018

1 reference

Improved vectors and genome-wide libraries for CRISPR screening

21 January 2018

1 reference

HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency

21 January 2018

1 reference

The PARP inhibitor Olaparib disrupts base excision repair of 5-aza-2'-deoxycytidine lesions

21 January 2018

1 reference

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

21 January 2018

1 reference

Cellular pharmacology and optimal therapeutic concentrations of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in leukemic blasts during treatment of refractory leukemia with high-dose 1-beta-D-arabinofuranosylcytosine

21 January 2018

1 reference

12 December 2020

Influence of clofarabine on transcriptional activity of PTEN, APC, RARB2, ZAP70 genes in K562 cells.

1 reference

12 December 2020

Uptake and phosphorylation of cytosine arabinoside by normal and leukemic human blood cells in vitro

1 reference

12 December 2020

Prognostic value of in vitro uptake and retention of cytosine arabinoside in acute myelogenous leukemia.

1 reference

12 December 2020

Relationships among Ara-CTP pools, formation of (Ara-C)DNA, and cytotoxicity of human leukemic cells

1 reference

12 December 2020

Rationales for a pharmacologically optimized treatment of acute nonlymphocytic leukemia with cytosine arabinoside.

1 reference

12 December 2020

Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria.

1 reference

12 December 2020

Variables predicting response to high dose cytosine arabinoside therapy in patients with refractory acute leukemia

1 reference

12 December 2020

Identifiers

DOI

10.1038/NM.4265

1 reference

3 August 2017

1 reference